ArticleJournal of neural transmission (Vienna, Austria : 1996)2025

Safety of COMT-inhibitors in parkinson's disease: a phase-IV comparative study on adverse events of Tolcapone, Entacapone and Opicapone.

Pasquale Maria Pecoraro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.